Sun Pharmaceutical Industries Ltd Sees Surge in Call Options with 30,312 Contracts Traded

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the market today, particularly in the options segment. The company, a key player in the Pharmaceuticals & Drugs industry, has seen significant trading activity in call options with expiry dates set for April 24, 2025. Notably, the call option with a strike price of Rs 1820 recorded 11,492 contracts traded, generating a turnover of approximately Rs 1,010.38 lakhs, while the Rs 1800 strike price option saw 18,820 contracts traded with a turnover of around Rs 2,314.19 lakhs.
The underlying value of Sun Pharma is currently at Rs 1770.0, reflecting a strong market position with an open interest of 2,999 for the Rs 1820 strike and 3,287 for the Rs 1800 strike. Performance metrics indicate that the stock has outperformed its sector by 1.11%, gaining 4.03% over the last two days. Today, it opened with a gap up of 2.41% and reached an intraday high of Rs 1812.7, marking a 5.78% increase.

Sun Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend. The stock's liquidity remains strong, with a delivery volume of 26.1 lakhs on April 2, reflecting a 54.45% increase compared to the 5-day average. Overall, Sun Pharmaceutical Industries Ltd continues to demonstrate notable activity and resilience in the current market landscape.